Helix Biopharma Corp. HBPCF
—
1.71
0.00
0.00%
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow HBPCF
Growth Flags
show if company had growth for consecutive years
| Older periods | Jul '25 | Oct '25 | Jan '26 | Apr '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.06 | 0.18 | 0.02 | 0.43 | |
Current Ratio |
0.13 | 0.23 | 0.04 | 0.45 | |
Net Debt/EBITDA |
(0.28) | 0.16 | (0.48) | 3.60 | |
Debt/Assets |
1.78% | 1.85% | 1.94% | 1.68% | |
Debt/Equity |
0.02 | 0.02 | 0.02 | 0.02 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.72 | 1.21 | 0.66 | 1.34 | |
Capex/Depreciation |
0.22 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.98 | 0.96 | 0.99 | 0.86 | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.01) | 0.00 | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.01) | (0.01) | 0.00 | (0.01) | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.03 | |
Shareholders Equity per Share |
0.20 | 0.15 | 0.15 | 0.14 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.20 | 0.15 | 0.15 | 0.14 | |
Free Cash Flow |
(0.51) | (0.88) | (0.33) | (0.65) | |
Working Capital |
(2.01) | (1.68) | (2.18) | (2.70) | |
Capital Expenditures |
0.00 | — | — | — | |
Net Current Asset Value |
(2.01) | (1.68) | (2.18) | (2.70) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.06 | 0.03 | 0.02 | 0.02 | |
Average Payables |
1.61 | 1.60 | 1.81 | 1.81 | |
Average Assets |
7.29 | 7.02 | 7.47 | 8.15 | |
Average Common Equity |
5.55 | 5.29 | 5.53 | 4.87 |
Columns are period end dates